Preclinical Studies on Herbal Extract and Phytochemical as Monocyte Chemoattractant Protein-1 (MCP - 1) Inhibitor in Diabetic Complications

Ítems similars

• Preclinical Studies on Herbal Extract and Phytochemical as Monocyte Chemoattractant Protein-1 (MCP-1) Inhibitor for Diabetic Complications
  per: Kaveri Adki
• Preclinical Studies on Daidzein in the Treatment of Diabetic Complications
  per: Laddha Ankit P.
  Publicat: (2021)
• Targeting NF-κβ by natural Products in the Management of Vascular Complications of Diabetes
  per: Suryavanshi Sachin Vilas
  Publicat: (2021)
• Study of Naturally Occurring Flavones in the Treatment of Vascular Complications of Diabetes
  per: Parkar Nishad
  Publicat: (2014)
• Targeting SIRTI By Isoflavone for the Treatment of Type 2 Diabetes and its Complications
  per: Oza Manisha
  Publicat: (2019)